Skip to main content

Advertisement

SpringerLink
Log in

cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

We have studied the effects of the chemotherapeutic drug cis-diamminedichloroplatinum(II) (cisplatin) on three human ovarian carcinoma cell lines one sensitive to the drug (CHI), one with acquired resistance (CHlcisR) and one with intrinsic resistance (SKOV-3). Previous work has shown that the 50% inhibitory concentrations (IC50 values) after a 2-h exposure to the drug are: CHI, 2.5 (µM; CHlcisR, 7.5 µM; and SKOV-3, 33 µM. Despite the variation in sensitivity, the amount of Pt bound to DNA and the rate of removal of Pt was similar for the three lines. There were significant differences in the rates of formation of DNA cross-links but these were not large enough to account for the high resistance of the SKOV-3 line. We have reported that in the L1210 murine leukaemia cell line there are two mechanisms of cisplatin-induced cell death — one of which involves apoptosis. In this paper, we report on an investigation into whether sensitivity to apoptosis played a role in the resistance of these ovarian lines towards cisplatin. After a 2-h incubation with the drug, cells from the three lines showed evidence of death through apoptosis. The cells detached from the culture dish in a time- and dose-dependent fashion. These cells morphologically were quite distinctive from the attached cells and showed changes in their chromatin structure indicative of apoptosis. Their DNA had not been degraded into oligonucleosomal fragments (200 bp and multiples thereof) but had been cut into larger fragments (30 kilobase pairs, kbp) of a size associated with chromatin domains (chromatin loops). At equitoxic doses of drug, the quantity of cells undergoing apoptosis was similar for the three cell lines. The most prominent effect on cell-cycle kinetics was a slowdown in S-phase transit during which the cells underwent apoptosis. Cells that successfully completed the S phase subsequently suffered a temporary G2 block. We propose that the sensitivity of these cell lines to cisplatin was governed by their ability to handle damage caused by platination of the DNA and that the major mechanism of cisplatin-induced cell death in all three cell lines was the induction of apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin, perspectives on mechanisms of acquired resistance. Cancer Cells 2:35

    PubMed  CAS  Google Scholar 

  2. Arends MJ, Wyllie AH (1991) Apoptosis, mechanisms, role in pathology. Int Rev Exp Pathol 32:223

    PubMed  CAS  Google Scholar 

  3. Arends MJ, Morris RG, Wyllie AH (1990) Apoptosis. The role of endonuclease. Am J Pathol 136: 595

    Google Scholar 

  4. Barry MA, Behnke CA, Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol40:2353

    Article  PubMed  CAS  Google Scholar 

  5. Boe R, Gjersten BT, Vintermyr OK, Houge H, Lanotte M, Doskeland SO (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res 195:237

    Article  PubMed  CAS  Google Scholar 

  6. Bramson J, Panasci LC (1993) Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents. Cancer Res 53:3237

    PubMed  CAS  Google Scholar 

  7. Brown DG, Sun X-M, Cohen GM (1993) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 268:3037

    PubMed  CAS  Google Scholar 

  8. Cohen GM, Sun X-M, Snowden RT, Dinsdale D, Skilleter DN (1992) Morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286:331

    PubMed  CAS  Google Scholar 

  9. Collins RJ, Harmon BV, Gobé GC, Kerr JF (1992) Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451

    Article  PubMed  CAS  Google Scholar 

  10. Compton MM (1992) A biochemical hallmark of apoptosis, internucleosomal degradation of the genome. Cancer Metastasis Rev 11:105

    Article  PubMed  CAS  Google Scholar 

  11. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13:795

    Article  PubMed  CAS  Google Scholar 

  12. De Graeff A, Slebos RJ, Rodenhuis S (1988) Resistance to cisplatin, analogues: mechanisms, potential clinical implications. Cancer Chemother Pharmacol. 22:325

    Article  PubMed  Google Scholar 

  13. Demarcq C, Bastian B, Remvikos Y (1992) BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloro-platinum(II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry 13:416

    Article  PubMed  CAS  Google Scholar 

  14. Dive C, Hickman JA (1991) Drug-target interactions, only the first step in the commitment to a programmed cell death? Br J Cancer 64:192

    PubMed  CAS  Google Scholar 

  15. Evan G, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119

    Article  PubMed  CAS  Google Scholar 

  16. Evans DL, Dive C (1993) Effects of cisplatin on the induction apoptosis in proliferating hepatoma cells, non proliferating immature thymocytes. Cancer Res. 53:2133

    PubMed  CAS  Google Scholar 

  17. Evans DL, Tilby M, Dive C (1994) Differential sensitivity to the induction of apoptosis by cisplatin in proliferating, quiescent immature rat thymocytes is independent of the levels of drug accumulation, DNA adduct formation. Cancer Res 54:1596

    PubMed  CAS  Google Scholar 

  18. Fearnhead HO, Chwalinski M, Snowden RT, Ormerod MG, Cohen GM (1984) Dexamethasone and etoposide induce apoptosis in rat thymocytes from different phases of the cell cycle. Biochem Pharmacol 48:1073

    Article  Google Scholar 

  19. Fogh J, Fogh JM, Orfeo T (1977) One hundred twenty-seven cultured tumour cell lines producing tumours in nude mice. J Natl Cancer Inst 59:221

    PubMed  CAS  Google Scholar 

  20. Fraval HNA, Roberts JJ (1978) Effects of cis-platinumdiam-minedichloride on survival, the rate of DNA synthesis in synchronously growing Chinese hamster V79-379A cells in the absence presence of caffeine inhibited post replication repair, evidence for an inducible repair mechanism. Chem Biol Interact 23:99–110

    Article  PubMed  CAS  Google Scholar 

  21. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11:121

    Article  PubMed  CAS  Google Scholar 

  22. Hill BT, Shellard SA, Fichtinger-Schepman AM, Schmoll HJ, Harstrick A (1994) Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines. Anticancer Drugs 5:321

    Article  PubMed  CAS  Google Scholar 

  23. Hills CA, Kelland LR, Abel G, Siracky J, Wilson AP, Harrap KR (1989) Biological properties of ten human ovarian carcinoma cell lines, calibration in vitro against four platinum complexes. Br J Cancer 59:527

    PubMed  CAS  Google Scholar 

  24. Hromas RA, Andrews PA, Murphy MP, Burns CP (1987) Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells. Cancer Lett 34:9

    Article  PubMed  CAS  Google Scholar 

  25. Kanter P, Leister KJ, Tomei LD, Wenner PA, Wenner CE (1992) Epidermal growth factor, tumour promoters prevent DNA fragmentation by different mechanisms. Biochem Biophys Res Commun 11:392

    Google Scholar 

  26. Karran P, Bignami M (1994) DNA damage tolerance, mismatch repair and genome instability. Bioessays 16:833

    Article  PubMed  CAS  Google Scholar 

  27. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304

    PubMed  CAS  Google Scholar 

  28. Kelland LR, Mistry P, Abel G, Lob SY, O’Neill CF, Murrer BA, Harrap KR (1992) Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res 52:3857

    PubMed  CAS  Google Scholar 

  29. Kerr JFR, Harmon BV (1991) Definition, incidence of apoptosis, an historical perspective. In: Tomei LD, Cope FO (eds) Apoptosis, the molecular basis of cell death. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York pp. 5–29

    Google Scholar 

  30. Lane DP (1992) p53, guardian of the genome. Nature 358:15

    Article  PubMed  CAS  Google Scholar 

  31. Loehrer PJ, Einhorn LH (1984) Cisplatin, diagnosis, treatment. Ann Intern Med 100:704

    PubMed  CAS  Google Scholar 

  32. Lowe SW, Rutley HE, Jacks T, Housman DE. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957

    Article  PubMed  CAS  Google Scholar 

  33. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Tyler J (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847

    Article  PubMed  CAS  Google Scholar 

  34. Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25:229

    Article  PubMed  CAS  Google Scholar 

  35. Nicolson MC, Orr RM, O’Neill CF, Harrap KR (1992) The role of platinum uptake, glutathione levels in L1210 cells sensitive, resistant to cisplatin, tetraplatin or carboplatin. Neoplasma 39:189

    PubMed  CAS  Google Scholar 

  36. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Shulte-Hermann R (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-βl. Proc Natl Acad Sci USA 89:5408

    Article  PubMed  CAS  Google Scholar 

  37. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M (1993) Apoptotic death in epithelial cells, cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679

    PubMed  CAS  Google Scholar 

  38. O’Neill CF, Orr RM, Kelland LR, Harrap KR (1992a) Studies of Pt/DNA interactions in human ovarian carcinoma cell lines sensitive, resistant to cisplatin (abstract). Br J Cancer 65 [Suppl XVI]: 64

    Google Scholar 

  39. O’Neill CF, Orr RM, Kelland LR, Harrap KR (1992b) Formation, removal of platinum/DNA adducts in human ovarian carcinoma cell lines sensitive, resistant to cisplatin (abstract). Proc Am Assoc Cancer Res 33: 535

    Google Scholar 

  40. O’Neill CF, Orr RM, Kelland LR, Harrap KR (1995) Comparison of platinum (Pt) binding to DNA, and removal of total Pt adducts and inter-strand cross-links in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. Cell Pharmacol 2:1

    CAS  Google Scholar 

  41. Ormerod MG (1994a) Analysis of DNA. General methods. In: Ormerod MG (ed) Flow cytometry. A practical approach, 2nd edn. IRL Press Oxford University Press, Oxford, pp 119–135

    Google Scholar 

  42. Ormerod MG (1994b) Further applications to cell biology. In: Ormerod MG (ed) Flow cytometry. A practical approach, 2nd ed. IRL Press Oxford University Press, Oxford pp 261–273

    Google Scholar 

  43. Ormerod MG (1994c) Flow cytometry. Bios, Oxford

    Google Scholar 

  44. Ormerod MG, Payne AWR, Watson JV (1987) Improved program for the analysis of DNA histograms. Cytometry 8:637

    Article  PubMed  CAS  Google Scholar 

  45. Ormerod MG, Collins MKL, Rodriguez-Tarduchy G, Robertson D (1992) Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J Immunol Methods 153:57

    Article  PubMed  CAS  Google Scholar 

  46. Ormerod MG, O’Neill CF, Orr RM, Robertson D, Titley JC, Kelland L, Harrap KR (1994) Cytotoxicity of platinum drugs: role of apoptosis (abstract). Cytometry [Suppl] 7:24

    Google Scholar 

  47. Ormerod MG, O’Neill CF, Robertson D, Harrap KR (1994) Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res 206:231

    Article  Google Scholar 

  48. Ormerod MG, Orr RM, Peacock JH (1994) The role of apoptosis in cell killing by cisplatin, a flow cytometric study. Br J Cancer 69:93

    PubMed  CAS  Google Scholar 

  49. Perez RP, Godwin AK, Handel LM, Hamilton TC (1993) A comparison of clonogenic, microtetrazolium and sulfor-hodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur J Cancer 29A: 395

    Article  PubMed  CAS  Google Scholar 

  50. Piacentini M, Fesus L, Melino G (1993) Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett 320:150

    Article  PubMed  CAS  Google Scholar 

  51. Rampino NJ, Bohr VA (1994) Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early Gl phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polymerase. Proc Natl Acad Sci USA 91:10977

    Article  PubMed  CAS  Google Scholar 

  52. Richon VM, Schulte N, Eastman A (1987) Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) on murine leukemia L1210 cells. Cancer Res 47:2056

    PubMed  CAS  Google Scholar 

  53. Salles B, Butour JL, Macquet JP (1983) cis-Pt(NH3)2Cl2, trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells. Biochem Biophys Res Commum 112:555

    Article  CAS  Google Scholar 

  54. Sheibani N, Jennerwein MM, Eastman A (1989) DNA repair in cells sensitive, resistant to cis-diamminedichloroplatinum(II); host cell reactivation of damaged plasmid DNA. Biochemistry 28:3120

    Article  PubMed  CAS  Google Scholar 

  55. Shellard SA, Hosking LK, Hill BT (1991) Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Cancer Res 51:455

    Google Scholar 

  56. Sorenson CM, Eastman A (1988) Influence of cis-diamminedich-loroplatinum(II) on DNA synthesis, cell cycle progression in excision repair proficient, deficient Chinese hamster ovary cells. Cancer Res 48:6703

    PubMed  CAS  Google Scholar 

  57. Sorenson CM, Barry MA, Eastman A (1990) Analysis of events associated with cell cycle arrest at G2 phase, cell death induced by cisplatin. J Natl Cancer Inst 82:749

    Article  PubMed  CAS  Google Scholar 

  58. Tomei LD, Shapiro JP, Cope FO (1993) Apoptosis in C3H/10T1/2 mouse embryonic cells, evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 90:853

    Article  PubMed  CAS  Google Scholar 

  59. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF, Sikorska M (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51:1078

    PubMed  CAS  Google Scholar 

  60. Walton MI, Koshy P, Wu E, Kelland LR (1995) Molecular characterisation of a panel of human ovarian cancers with respect to p53 status and cis-platinum chemosensitivity (abstract 121). Proceedings, 7th international symposium on platinum and other metal co-ordination compounds in cancer chemotherapy, European Cancer Centre, Amsterdam, March 1–4

  61. Wiltshaw E, Carr B (1984) cis-Platinumdiamminedichloride. In: Connors TA, Roberts JJ (eds) Platinum coordination complexes in cancer chemotherapy. Springer, Berlin Heidelberg New York, pp 178–182

    Google Scholar 

  62. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endonuclease activation. Nature 284:555

    Article  PubMed  CAS  Google Scholar 

  63. Wyllie AH (1988) Apoptosis. ISI Atlas Sci Immunol 1:192

    Google Scholar 

  64. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death, the significance of apoptosis. Int Rev Cytol 68:251

    Article  PubMed  CAS  Google Scholar 

  65. Yaginuma Y, Westphal H (1992) Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res 52:4196

    PubMed  CAS  Google Scholar 

  66. Zhen W, Link CJ, O’Connor PM, Reed E, Parker R, Howell SB, Bohr VA (1992) Increased gene-specific repair of cisplatin inter-strand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 12:3689

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Michael G. Ormerod

    Present address: , 34 Wray Park Road, RH2 ODE, Reigate, UK

Authors and Affiliations

  1. Cancer Research Campaign Centre For Cancer Therapeutics, Institute of Cancer Research, Royal Cancer Hospital, Cotswold Road, SM2 5NG, Sutton, UK

    Michael G. Ormerod, Ciaran O’Neill, Lloyd R. Kelland & Kenneth R. Harrap

  2. Section of Cell and Experimental Pathology, Institute of Cancer Research, Royal Cancer Hospital, Costwold Road, SM2 5NG, Sutton, UK

    David Robertson

Authors
  1. Michael G. Ormerod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ciaran O’Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lloyd R. Kelland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenneth R. Harrap
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ormerod, M.G., O’Neill, C., Robertson, D. et al. cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 37, 463–471 (1996). https://doi.org/10.1007/s002800050413

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002800050413

Key words

Search

Navigation